Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD and Safety of Leucostim vs Neupogen in Healthy Volunteers
NCT02762799Phase 1Completed
- Sponsor
- BIOCAD
- Start
- Jul 2016
- Primary completion
- Nov 2016
- Modality
- Cytokines & Interferons
01
Overview
Phase 1, randomised, open-label trial of filgrastim in neutropenia (4 arms), sponsored by BIOCAD. Primary endpoints: Area Under the Curve (0-48 Hours) and Maximum Concentration After Subcutaneous Injection. Started Jul 2016; status: completed.
02
Drugs
filgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT02762799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02762799.